Integral Health Asset Management, LLC
Q3 2025 13F Holdings
- Locationnew york, NY
- Num holdings
76
- Value ($000)
$1,478,112
- Date Filed11/14/2025
- Form type13F-HR
- CIK0001773206
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
INSM INSMED INC | COM PAR $.01 | 457669307 | $230.42 M | 16 % | 1,600,000 | ||
CYTK CYTOKINETICS INC | COM NEW | 23282W605 | $76.94 M | 5 % | 1,400,000 | ||
THC TENET HEALTHCARE CORP | COM NEW | 88033G407 | $60.91 M | 4 % | 300,000 | ||
MLYS MINERALYS THERAPEUTICS INC | COM | 603170101 | $56.88 M | 4 % | 1,500,000 | ||
VERA VERA THERAPEUTICS INC | CL A | 92337R101 | $49.40 M | 3 % | 1,700,000 | ||
CYTK CYTOKINETICS INC | COM NEW | 23282W605 | $41.22 M | 3 % | 750,000 | call | |
UNIQURE NV | SHS | N90064101 | $35.02 M | 2 % | 600,000 | ||
BTSG BRIGHTSPRING HEALTH SVCS INC | COM | 10950A106 | $33.99 M | 2 % | 1,150,000 | ||
BSX BOSTON SCIENTIFIC CORP | COM | 101137107 | $29.29 M | 2 % | 300,000 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | $28.44 M | 2 % | 1,000,000 | put |
Rows Per Page
10
- 10
- 50
- 100